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Abstract
A 76-year-old male non-smoker presented to our institution with cough and
haemoptysis. He had been treated for cavitatory pulmonary Mycobacterium
tuberculosis of the right upper lobe 10 years previously. Chest radiograph and
subsequent computed tomography (CT) of the chest demonstrated a right
upper cavity containing a mass suspicious for mycetoma. Flexible bronchos-
copy under conscious sedation demonstrated a mass obstructing the anterior
segment of the right upper lobe. The abnormality was subsequently removed
using a flexible endobronchial cryoprobe. Histopathological analysis demon-
strated abundant fungal organisms morphologically consistent with Aspergillus
species. Microbiological culture of the bronchoalveolar lavage (BAL) from the
cavity isolated both Aspergillus fumigatus and Staphylococcus aureus. The
patient was commenced on the anti-fungal drug posaconazole and received a
course of flucloxacillin. Three months later, there was no endobronchial
obstruction and lavage of the affected cavity again isolated Staphylococcus
aureus without Aspergillus species. Repeat thoracic CT and flexible bronchos-
copy demonstrated no further re-occurrence of the mycetoma at 3 months.
Introduction
A pulmonary mycetoma is a fungus ball that fills a pre-
existing cavity. Most commonly, these cavities result from
tuberculosis (TB), sarcoidosis, or cystic fibrosis [1]. Symp-
tomatology is diverse, ranging from asymptomatic to life-
threatening haemoptysis, particularly in those patients with
TB [2]. In symptomatic patients, the mainstay of treatment is
surgical resection. However, this is often limited by patient
co-morbidities, specifically underlying lung conditions. Previ-
ously, medical intervention included oral anti-fungal agents
and inhaled or intracavitatary instillation of anti-fungal drugs
[1]. Therapeutic success of non-surgical interventions has
generally been limited. The advent of the flexible cryoprobe
offers a novel approach to the removal of mycetoma in
patients in whom the mycetoma is endoscopically visible. We
report a case of successful removal of mycetoma endoscopi-
cally using a flexible cryoprobe in combination with lavage.
Case Report
A 76-year-old male presented to our institution with
chronic cough and intermittent haemoptysis for 2 months.
He had completed standard anti-TB therapy 10 years prior
for smear positive cavitatory pulmonary Mycobacterium
tuberculosis. Other past medical history was significant for
rheumatic fever. He was a lifelong non-smoker. Thoracic
computed tomography (CT) done 7 years previously
demonstrated traction bronchiectasis and chronic scarring
within the right upper lobe. He remained symptomatically
well until this presentation.
His physical examination revealed bronchial breath
sounds in the right upper lobe. Thoracic CT demonstrated
fibrocystic change in an incompletely collapsed right upper
lobe. There was now a large cavity with a new 2.1-cm
round mass (Fig. 2A, C).
We proceeded to perform flexible bronchoscopy
(Olympus 3.2 mm) under conscious sedation. After tra-
versing two segments of the bronchi, an abnormal
rounded mass was seen obstructing the anterior segment
of the right upper lobe (Fig. 1A). Microbiological culture
of bronchoalveolar lavage (BAL) from the right upper
lobe cavity subsequently isolated both Staphylococcus
aureus and Aspergillus fumigatus. He was commenced on
a one week course of flucloxacillin as well as a prolonged
course of the anti-fungal drug posaconazole. He was
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subsequently discharged and electively readmitted a few
weeks later to facilitate bronchoscopic removal of the
mycetoma.
At repeat flexible bronchoscopy, a flexible cryoprobe
was inserted via the bronchoscope into the cavity. How-
ever, en bloc removal of the mass was not possible. The
Figure 1. (A) Mycetoma within
endobronchial cavity (anterior seg-
ment of right upper lobe) being
removed with cryoprobe. (B) Endo-
bronchial cavity once mycetoma has
been removed.
Figure 2. Axial image demonstrating
(A) mycetoma in right upper lobe
and (B) endobronchial cavity once
mycetoma has been removed. Sagit-
tal image demonstrating (C) myce-
toma in right upper lobe and
(D) endobronchial cavity once myce-
toma has been removed.
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cryoprobe was removed and hot forceps was introduced to
subdivide the mass into various smaller parts. Then the
cryoprobe was reintroduced and the subdivided mass was
removed piecemeal. Washing of the cavity was then per-
formed with normal saline until all macroscopically visible
mycetoma had been removed. Inspection of the empty
cavity revealed inflamed haemorrhagic mucosa (Fig. 1B).
The obtained mass was sent for histopathological analy-
sis. Microscopically, it demonstrated inflamed bronchial
mucosa, abundant fungal organisms as well as a bacterial
colony consistent with Gram-positive cocci. There was no
evidence of invasive fungal infection. The case was dis-
cussed at our institution’s multidisciplinary respiratory
meeting, where a diagnosis of mycetoma was inferred. He
was continued on oral posaconazole. Radiological and
bronchoscopic surveillance at 3 months demonstrated no
reoccurrence of the mycetoma (Figs. 1B, 2B, 2D).
Discussion
A mycetoma is a ball of fungal hyphae formed in a pre-
existing cavity of the lung, usually within the upper lobes.
Cavities can occur following a variety of pathological
insults to the lung, most commonly with TB, sarcoidosis,
and cystic fibrosis. The fungal ball is composed of hyphae,
inflammatory cells, and fibrin. The majority of mycetomas
are asymptomatic. The most common symptom is hae-
moptysis ranging from mild to life-threatening. Surgical
intervention is the mainstay of treatment with inconsistent
clinical results from medical therapy. Medical intervention
has consisted mainly of anti-fungal agents administered
systemically or by direct installation into the mycetoma-
containing cavity. However, in general the success of this
pharmacological approach has been limited. Surgical inter-
vention has mainly consisted of wedge resection/segmen-
tectomy, cavernostomy, or thoracoplasty [2]. However,
surgical resection of the affected cavity is associated with a
high complication rate and reported mortality ranging
from 7 to 23% [1]. This is often attributed to poor lung
function due to underlying co-morbid pulmonary disease.
Previously, the flexible bronchoscopy was reserved only
for the visualization of a bleeding site prior to surgery.
Bronchoscopic visualization of a mycetoma is rare, and
this observation is exploited to facilitate endoscopic treat-
ment [3,4]. Since the introduction of the flexible cryop-
robe, it has been utilized in the diagnosis of interstitial
lung disease, foreign body removal, and in the treatment
of central airway obstruction (benign and malignant).
More recently, its utilization in the removal of mycetoma
has been reported [5]. Such bronchoscopic intervention
affords an opportunity for proximal cavitatory mycetoma
removal in individuals in whom the lesion is visible endo-
scopically. Our patient had pulmonary lung function that
would not have precluded him from surgery. However,
given the proximal location and visibility of the mycetoma
at bronchoscopy, and patient cooperation using conscious
sedation, removal was attempted and successful, with no
immediate complications. We propose the use of cryother-
apy for the removal of proximal mycetoma in suitable
patients.
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